Stay updated on Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe locations list was updated to replace many U.S. sites with international sites (Gauteng, KwaZulu-Natal, Western Cape, Gyeonggi-do); revision: v3.3.3.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.3.2 was released, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded notes clarifying that publications are automatically filled in from PubMed and updated the revision to v3.3.1. Removed the previous wording stating that publications come from PubMed and are automatically created by ClinicalTrials.gov, with revision updated to v3.2.0.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding lapse notice that warned information may not be up to date and pointed users to NIH/OPM status pages.SummaryDifference0.2%

- Check63 days agoChange DetectedThe page content remains the same; only visual formatting and layout differences are visible across the two screenshots.SummaryDifference0.2%

- Check91 days agoChange DetectedCore content updated: new operating-status notice and a version bump to v3.2.0; the previous version reference v3.0.2 was removed.SummaryDifference3%

Stay in the know with updates to Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page.